000			03311nam a2200337 i 4500
999			_c402485 _d402485
001			402485
003			ES-MaUEC
005			20240802100408.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			230610s2023 sz | fo |||| 0|eng d
020			_a9783031285363
024	7		_a10.1007/978-3-031-28536-3 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRA644 .C67 _b2023 EB
245	0	0	_aDiabetes and COVID-19 : _bConsiderations and Clinical Management _cedited by Alyson K. Myers
250			_a1st ed. 2023
264		1	_aCham _bSpringer International Publishing _c2023
300			_a1 recurso en línea
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aContemporary Endocrinology _x2523-3793
505	0		_aCOVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention -- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance -- Risk of COVID-19 in Persons with Diabetes -- Pathophysiology of Lung Dysfunction in Diabetes -- Diabetic kidney disease and COVID-19 -- The Impact of COVID-19 on Diabetic Foot Ulcers -- Co-morbid obesity and its impact on diabetes and COVID-19 -- Overview of Inpatient Mgt of Diabetes and COVID 19 -- Management of critically ill persons with COVID-19 and diabetes -- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes -- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19) -- COVID-19 Vaccination in Persons with Diabetes -- COVID-19 Vaccination in Persons with Diabetes -- Long-haul COVID Symptoms in Person with Diabetes.
520			_aManaging COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine. Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions. .
988			_aSpringer_Medicine_2023
650		7	_2embne _9683668 _aCOVID-19
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-28536-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b08/2024 _dz _eb _zSI